Tag #Journavx

Showing 1 to 3 of 3 results

cnbc.com
🌐 85% Global Worthiness
News related image

FDA Approves Novel Non-Opioid Painkiller Journavx

The FDA approved Vertex's non-opioid painkiller, Journavx, for moderate-to-severe acute pain, offering an addiction-free alternative impacting 80 million annual U.S. patients and potentially generating over $1 billion in annual sales.

Progress

44% Bias Score

Good Health and Well-being
cnnespanol.cnn.com
🌐 85% Global Worthiness
News related image

FDA Approves First New Non-Opioid Painkiller in Over Two Decades

The FDA approved suzetrigina, a new non-opioid painkiller, offering an alternative to opioids for acute pain; studies show comparable effectiveness to Vicodin for post-surgical pain, but further research is needed for chronic pain.

Progress

48% Bias Score

Good Health and Well-being
abcnews.go.com
🌐 85% Global Worthiness
News related image

FDA Approves First New Non-Opioid Painkiller in Over 20 Years

The FDA approved Journavx (suzetrigine), a non-opioid painkiller, to treat moderate to severe acute pain in adults; clinical trials showed it reduced pain by 50% in 48 hours and is as effective as hydrocodone, but non-addictive.

Progress

48% Bias Score

Good Health and Well-being

Showing 1 to 3 of 3 results